Paper Details

  1. Home
  2. Paper Details

Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients.

Author: HarderBjörn C, JarczokMarc N, SchlichtenbredeFrank C, SchusterAlexander K, TesarzJonas

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This research compares the effectiveness and ocular complications associated with acyclovir and valacyclovir for the treatment of herpes zoster ophthalmicus. While valacyclovir has improved bioavailability, further research is needed to determine if it offers superior treatment outcomes.
Paper Details　
Original Abstract of the Article :
Herpes zoster ophthalmicus affects the eye and vision, and is caused by the reactivation of the varicella zoster virus in the distribution of the first division of the trigeminal nerve. An aggressive management of acute herpes zoster ophthalmicus with systemic antiviral medication is generally recom...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464932/

データ提供：米国国立医学図書館（NLM）

Herpes Zoster Ophthalmicus: Exploring Treatment Options

This research compares the effectiveness of valacyclovir and acyclovir in treating herpes zoster ophthalmicus (HZO), a viral infection affecting the eye. Researchers aimed to evaluate the clinical outcomes and ocular complications associated with each antiviral medication.

Valacyclovir vs. Acyclovir: A Race Against Time

This study explores the therapeutic efficacy of valacyclovir and acyclovir in treating HZO. Imagine a desert race, where two camels compete for the finish line. Valacyclovir, with its improved bioavailability and steadier plasma concentration, holds an advantage. This research investigates whether this translates into better clinical outcomes and fewer ocular complications, offering valuable insights into the optimal treatment approach for HZO.

Herpes Zoster Ophthalmicus: Navigating the Landscape of Antiviral Treatment

This study provides valuable information for clinicians treating HZO. Understanding the differences in bioavailability and efficacy between valacyclovir and acyclovir can guide treatment decisions and potentially improve patient outcomes. The study emphasizes the importance of choosing the most appropriate antiviral medication to effectively manage HZO and minimize the risk of ocular complications.

Dr.Camel's Conclusion

This research provides a comprehensive comparison of valacyclovir and acyclovir in treating HZO. Just as a camel navigates a desert landscape, healthcare providers need to navigate the complex world of antiviral treatment options, choosing the most effective medication to optimize patient outcomes.
Date :
  1. Date Completed 2016-12-22
  2. Date Revised 2021-01-09
Further Info :

Pubmed ID

27841441

DOI: Digital Object Identifier

PMC6464932

Related Literature

Article Analysis
・Side Effects of valacyclovir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.